Veracyte to Acquire HalioDx for Global Cancer Diagnostics Growth
Aitechpark02 Jun, 2021Technology
Fueling growth by enabling IVD test development and manufacturing, deepening scientific capabilities and expanding cancer diagnostics scope to 8 of the 10 top cancers in the U.S. Investor conference call and webcast today at 8:00 a.m. ET Veracyte, Inc. (Nasdaq: VCYT) today announced it has reached the terms of an agreement to acquire HalioDx in a transaction to further accelerate growth and strengthen Veracyte?s global leadership in cancer diagnostics.
Related Bookmarks
- Guide To Solve Kindle Fire Won�t Turn On Error
- Where is the best place to find an affordable mobile app
- Detailed Guide to Install Rand McNally Dock
- iPhone App Development Company in Chennai
- Why Should you Choose Laptop Rental Services in Dubai?
- Wholesale Smart Home Devices & Systems Supplier
- Unable to Extract Zip File Windows 10, 8.1, 8, 7 - Error Resolved
- Cannot Open ZIP file as archive? - Get Instant Solution
- Zip file error 0x80004005 unzip - know the solution
- Restore BKF file Symantec backup exec - Step by Step Guide
Recent Profiles
Web Cures Digital
Bet88biz Shop
Airborne Air Hostess Academy
Universities Page
The Sleep Apnea Center Of Connecticut
Spinoy
Goog88
88vinpics
Pro Soccer Rebound
Kuailianoi